Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation

European Journal of Immunology

Volumn 41, Issue 2, 2011, Pages 392-402

  Oh, Keunhee ^a   Byoun, Ok Jin ^a   Ham, Don Il ^b   Kim, Yon Su ^a   Lee, Dong Sup ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Autoimmunity; NKT cells; Th differentiation

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOIMMUNE UVEITIS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TH17 CELL; UVEITIS; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD1D; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL COUNT; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; EYE; EYE PROTEINS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; OVALBUMIN; PEPTIDE FRAGMENTS; RETINOL-BINDING PROTEINS; TH1 CELLS; TH17 CELLS; UVEITIS; VACCINATION;

EID: 78851469543     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040569     Document Type: Article

References (42)

1. Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007. 25: 821-852.
2. Zhu, J. and Paul, W. E., CD4 T cells: fates, functions, and faults. Blood 2008. 112: 1557-1569.
3. McGeachy, M. J. and Cua, D. J., Th17 cell differentiation: the long and winding road. Immunity 2008. 28: 445-453.
4. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
5. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
6. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M. and Cheroutre, H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007. 317: 256-260.
7. Lohr, J., Knoechel, B., Wang, J. J., Villarino, A. V. and Abbas, A. K., Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 2006. 203: 2785-2791.
8. Stummvoll, G. H., DiPaolo, R. J., Huter, E. N., Davidson, T. S., Glass, D., Ward, J. M. and Shevach, E. M., Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008. 181: 1908-1916.
9. O'Connor, R. A., Malpass, K. H. and Anderton, S. M., The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+regulatory T cells. J. Immunol. 2007. 179: 958-966.
10. Radhakrishnan, S., Cabrera, R., Schenk, E. L., Nava-Parada, P., Bell, M. P., Van Keulen, V. P., Marler, R. J. et al., Reprogrammed FoxP3+T regulatory cells become IL-17+antigen-specific autoimmune effectors in vitro and in vivo. J. Immunol. 2008. 181: 3137-3147.
11. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. and Joosten, I., Human CD25high Foxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008. 112: 2340-2352.
12. Ahn, J. K., Chung, H., Lee, D. S., Yu, Y. S. and Yu, H. G., CD8bright CD56+T cells are cytotoxic effectors in patients with active Behcet's uveitis. J. Immunol. 2005. 175: 6133-6142.
13. Caspi, R. R., Chan, C. C., Wiggert, B. and Chader, G. J., The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr. Eye. Res. 1990. 9: 169-174.
14. Sun, B., Rizzo, L. V., Sun, S. H., Chan, C. C., Wiggert, B., Wilder, R. L. and Caspi, R. R., Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J. Immunol. 1997. 159: 1004-1011.
15. Amadi-Obi, A., Yu, C. R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I. et al., TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 2007. 13: 711-718.
16. Tang, J., Zhu, W., Silver, P. B., Su, S. B., Chan, C. C. and Caspi, R. R., Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J. Immunol. 2007. 178: 5578-5587.
17. Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P. et al., Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008. 205: 799-810.
18. Kronenberg, M., Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 2005. 23: 877-900.
19. Bendelac, A., Savage, P. B. and Teyton, L., The biology of NKT cells. Annu. Rev. Immunol. 2007. 25: 297-336.
20. Oh, K., Kim, S., Park, S. H., Gu, H., Roopenian, D., Kim, Y. S. and Lee, D. S., Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J. Immunol. 2005. 174: 2030-2036.
21. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
22. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
23. Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagómez, D., Du, C., Stanic, A. K., Joyce, S. et al., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 1801-1811.
24. Mars, L. T., Gautron, A. S., Novak, J., Beaudoin, L., Diana, J., Liblau, R. S. and Lehuen, A., Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J. Immunol. 2008. 181: 2321-2329.
25. Hornung, M., Farkas, S. A., Sattler, C., Schlitt, H. J. and Geissler, E. K., DX5+NKT cells induce the death of colitis-associated cells: involvement of programmed death ligand-1. Eur. J. Immunol. 2006. 36: 1210-1221.
26. Mars, L. T., Araujo, L., Kerschen, P., Diem, S., Bourgeois, E., Van, L. P., Carrié, N. et al., Invariant NKT cells inhibit development of the Th17 lineage. Proc. Natl. Acad. Sci. USA 2009. 106: 6238-6243.
27. Mars, L. T., Laloux, V., Goude, K., Desbois, S., Saoudi, A., Van Kaer, L., Lassmann, H. et al., Cutting Edge: Va14-Ja281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 2002. 168: 6007-6011.
28. Grajewski, R. S., Hansen, A. M., Agarwal, R. K., Kronenberg, M., Sidobre, S., Su, S. B., Silver, P. B. et al., Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J. Immunol. 2008. 181: 4791-4797.
29. Yamamura, T., Miyamoto, K., Illés, Z., Pál, E., Araki, M. and Miyake, S., NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease. Curr. Top. Med. Chem. 2004. 4: 561-567.
30. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001. 413: 531-534.
31. Chiba, A., Oki, S., Miyamoto, K., Hashimoto, H., Yamamura, T. and Miyake, S., Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 2004. 50: 305-313.
32. Novak, J., Beaudoin, L., Griseri, T. and Lehuen, A., Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J. Immunol. 2005. 174: 1954-1961.
33. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
34. Nakamura, K., Kitani, A. and Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001. 194: 629-644.
35. Oida, T., Xu, L., Weiner, H. L., Kitani, A. and Strober, W., TGF-beta-mediated suppression by CD4+CD25+T cells is facilitated by CTLA-4 signaling. J. Immunol. 2006. 177: 2331-2339.
36. Grajewski, R. S., Hansen, A. M., Agarwal, R. K., Kronenberg, M., Sidobre, S., Su, S. B., Silver, P. B. et al., Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J. Immunol. 2008. 181: 4791-4797.
37. Avichezer, D., Chan, C. C., Silver, P. B., Wiggert, B. and Caspi, R. R., Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice. Exp. Eye. Res. 2000. 71: 111-118.
38. Minami, K., Yanagawa, Y., Iwabuchi, K., Shinohara, N., Harabayashi, T., Nonomura, K. and Onoé, K., Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions. Blood 2005. 106: 1685-1693.
39. Lees, J. R., Iwakura, Y. and Russell, J. H., Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J. Immunol. 2008. 180: 8066-8072.
40. Zamvil, S. S. and Steinman, L., Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron 2003. 38: 685-688.
41. Adamus, G. and Chan, C. C., Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int. Rev. Immunol. 2002. 21: 209-229.
42. Chan, C. C., Caspi, R. R., Ni, M., Leake, W. C., Wiggert, B., Chader, G. J. and Nussenblatt, R. B., Pathology of experimental autoimmune uveoretinitis in mice. J. Autoimmun. 1990. 3: 247-255.